Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3164
Peer-review started: July 17, 2021
First decision: October 16, 2021
Revised: October 25, 2021
Accepted: February 22, 2022
Article in press: February 22, 2022
Published online: April 6, 2022
Processing time: 255 Days and 2.6 Hours
Neuroendocrine carcinoma (NEC) of the esophagus is rare and highly aggressive, and lacks biological features. Currently, there are no established standard treatments for this cancer. In this report, we describe a patient with large-cell NEC of the esophagus who was successfully treated using endoscopic submucosal dissection (ESD) combined with adjuvant chemotherapy.
A 55-year-old woman presented with intermittent mild dysphagia for 2 mo. Gastroscopy revealed a disc-shaped protruding lesion about 18 mm × 18 mm in size on the upper esophagus. Endoscopic ultrasonography demonstrated that the bulged lesion originated from the muscularis mucosa. We assessed en bloc resections using ESD for therapeutic diagnosis to devise a safe and appropriate treatment. Histopathological examination revealed a poorly differentiated neoplasm comprising of large cells with marked nuclear atypia and multifocal necrosis. In addition, the specimens had a negative horizontal margin and vertical margins. Depth of invasion was classified as submucosa 2 (SM2) without lymphovascular invasion. These histopathological results were consistent with a diagnosis of esophageal NEC, large cell type. Adjuvant therapy has been considered for ESD patients with SM2/SM3 lesions and patients with poorly differentiated lesions. After comprehensive consideration, we initiated combination treatment, i.e., ESD plus adjuvant chemotherapy. The patient remained disease-free at the 2-year follow-up.
En bloc resection approach using ESD may play a vital role as a diagnostic and therapeutic modality for esophageal NEC.
Core Tip: We describe a patient with large-cell neuroendocrine carcinoma (NEC) of the esophagus who was successfully treated using endoscopic submucosal dissection (ESD) combined with adjuvant chemotherapy. No standard treatment strategies are available for esophageal NEC due to a lack of clinical studies and its rarity. En bloc resection approach using ESD may play a vital role as a diagnostic and therapeutic modality for esophageal NEC.